» Articles » PMID: 15016762

A Novel TEAD1 Mutation is the Causative Allele in Sveinsson's Chorioretinal Atrophy (helicoid Peripapillary Chorioretinal Degeneration)

Overview
Journal Hum Mol Genet
Date 2004 Mar 16
PMID 15016762
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

Sveinsson's chorioretinal atrophy (SCRA), also referred to as helicoid peripapillary chorioretinal degeneration or atrophia areata, is an autosomal dominant eye disease, characterized by symmetrical lesions radiating from the optic disc involving the retina and the choroid. Genome-wide linkage analysis mapped the SCRA gene to chromosome 11p15 in 81 patients from a large founder pedigree in Iceland. The parametric LOD score obtained was 18.9 using an autosomal dominant model with high penetrance. Crossover analysis of the linkage region with 51 markers identified a 593 kb segment shared by all patients. Sequencing exons of the only gene in this interval, the transcriptional enhancer TEAD1, revealed a novel missense mutation (Y421H) carried by all patients and none of the 502 controls. The mutation is in a conserved amino acid sequence in the C terminal of the protein, a potential binding site for YAP65 one of TEAD1's cofactors that is expressed in human retina as well as TEAD1 based on RT-PCR experiments. Therefore, we conclude that the mutation in the TEAD1 gene is the cause of Sveinsson's chorioretinal atrophy.

Citing Articles

New Horizons in Cancer Progression and Metastasis: Signaling Pathway.

Kuracha M, Radhakrishna U, Kuracha S, Vegi N, Gurung J, McVicker B Biomedicines. 2024; 12(11).

PMID: 39595118 PMC: 11591698. DOI: 10.3390/biomedicines12112552.


The Hippo signalling pathway and its impact on eye diseases.

Du Y J Cell Mol Med. 2024; 28(8):e18300.

PMID: 38613348 PMC: 11015399. DOI: 10.1111/jcmm.18300.


Identification of miR-671-5p and Its Related Pathways as General Mechanisms of Both Form-Deprivation and Lens-Induced Myopia in Mice.

Cui Z, Huang Y, Chen X, Chen T, Hou X, Yu N Curr Issues Mol Biol. 2023; 45(3):2060-2072.

PMID: 36975502 PMC: 10047131. DOI: 10.3390/cimb45030132.


The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer.

Cunningham R, Hansen C Clin Sci (Lond). 2022; 136(3):197-222.

PMID: 35119068 PMC: 8819670. DOI: 10.1042/CS20201474.


Tight junction protein ZO-2 modulates the nuclear accumulation of transcription factor TEAD.

Gallego-Gutierrez H, Gonzalez-Gonzalez L, Ramirez-Martinez L, Lopez-Bayghen E, Gonzalez-Mariscal L Mol Biol Cell. 2021; 32(15):1347-1358.

PMID: 34010016 PMC: 8694039. DOI: 10.1091/mbc.E20-07-0470.